Harvey J. Berger - Articles and news items


ARIAD announces that Iclusig(TM) receives positive CHMP opinion for approval in the European Union

Industry news, News / 22 March 2013 / Biosector 2

Positive opinion on the marketing authorization application for Iclusig™…

ARIAD announces appointment of European General Manager and other key members of leadership team

Industry news, News / 21 February 2013 / Biosector 2

ARIAD announced the appointment of Jonathan E. Dickinson…

Merck logo

EMA accepts marketing authorization application for Ridaforolimus, investigational mTOR inhibitor

Industry news, News / 18 August 2011 /

Merck to pay ARIAD $25 million milestone payment for acceptance of filing…

Merck logo

Merck and ARIAD announce presentation of results of Phase III SUCCEED trial

Industry news, News / 6 June 2011 / Merck

Merck and ARIAD Pharmaceuticals, Inc., announced the presentation of detailed results from the Phase III SUCCEED clinical trial…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...